@Boehringer has nabbed #FDA approval for #Cyltezo, making it the first interchangeable biosimilar for AbbVie’s bloc… https://t.co/MBkf5zEHYB
@Boehringer has nabbed #FDA approval for #Cyltezo, making it the first interchangeable biosimilar for AbbVie’s bloc… https://t.co/MBkf5zEHYB